Wake Forest Finds Oxaliplatin Dosage for Peritoneal Cancer
Researchers from Wake Forest University have completed a Phase I study that may help improve the survival rate for patients with appendix cancer or colorectal cancer that’s spread to their abdomen....
View ArticleMelanoma Treatment Trials Halted by Pfizer
Pharmaceutical company Pfizer Inc (NYSE: PFE) has announced they’re discontinuing Phase III clinical trials on tremelimumab, an experimental treatment for melanoma. The company terminated the trials...
View ArticleCream Treats Precancerous Vulva Lesions Linked to HPV
Dutch scientists have published a study showing a topical cream called imiquimod effectively treats lesions on the vulva before they become cancerous – a discovery that could one day help women exposed...
View ArticleCampaign Calls for Alternative Treatments in Clinical Trials
An alternative health company is asking citizens of the United Kingdom to support legislation which would include herbal supplements and other natural treatments in clinical trials comparing the...
View ArticleBoston Builds Better Mouse Model for Metastatic Cancer
Biologists at Boston College have developed a more effective mouse model for studying how cancer spreads through the human body. Boston’s team developed two cell lines which express all the major...
View ArticleMPD Blood Cancer Treatment Begins Human Trials
Researchers at the Dana-Farber Cancer Institute have begun Phase I clinical trials of a new drug designed to treat myeloproliferative diseases (MPD) that sometimes develop into acute myelogenous...
View ArticleProstate Cancer Treatment Effectiveness Could Rely on P53
A study led by the Fred Hutchinson Cancer Research Center suggests that tumors with intact P53 genes may respond better to prostate cancer treatments designed to target insulin-like growth factor 1...
View ArticleLipidoids Could Deliver RNAi Treatments Directly to Cancer
Scientists from the Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY) have discovered a method which makes it possible to deliver powerful RNA interference...
View ArticleAll UK Cancer Patients Will Get Information on Clinical Trials
Health officials in the United Kingdom are implementing a new program to ensure patients with cancer and other serious diseases are kept better informed about ongoing clinical research related to their...
View ArticleNorthwestern Nanodiamonds Kill the Cancer Left Behind
Scientists at Northwestern University have developed an innovative device that delivers drugs to cancer cells left inside the body after a tumor is surgically removed. The flexible microfilm device is...
View Article
